Lancôme has introduced Absolue Longevity MD, a new skincare line created in partnership with the Swiss biotechnology company Timeline. At the center of the launch is Mitopure® by Timeline, a highly purified form of urolithin A that the companies associate with longevity research and mitochondrial health.
For the beauty market, this launch is interesting not only as another premium novelty from Lancôme. It shows how major cosmetics brands are gradually changing the language of anti-aging skincare: instead of a direct focus on “fighting aging,” concepts such as skin longevity, cellular energy, skin resilience, its functional condition, and visible biological age are being used more and more often.
Mitopure® was previously known primarily in the supplement segment for supporting healthy aging. It is a patented form of urolithin A that Timeline develops in the context of supporting mitochondrial function. In Lancôme’s new line, this ingredient is used not as an oral supplement, but as part of topical cosmetic formulas applied to the skin.
In the company’s release, it is emphasized that mitochondria play an important role in cellular energy, renewal, and tissue resilience. With age, the efficiency of mitochondrial processes may decline, and this very topic is becoming one of the points of intersection between healthy aging research and modern cosmetology. For the beauty industry, this is an important signal: the concept of “skin quality” is increasingly being viewed not only through wrinkles, pigmentation, or loss of firmness, but also through the skin’s long-term ability to maintain a healthy appearance.
Absolue Longevity MD is built around three care models: Anticipate, Intercept, and Reset. They correspond to different stages of visible skin aging and different care logics: preventive, corrective, and restorative. This approach reflects the trend toward more personalized communication in skincare, where a product is positioned not simply by chronological age, but by the visible condition of the skin.
The Anticipate model is aimed at early visible signs of biological aging. Intercept is intended for the period when such changes are already beginning to appear more noticeably. Reset is designed for more mature skin, for which loss of firmness, reduced radiance, changes in texture, and other visible signs of aging are relevant. In each model, Mitopure® is combined with specific ingredient complexes, among which Lancôme mentions niacinamide, Matrixyl™, LHA, Rose Pro-Xylane, taurine, and other components depending on the specific formula.
Importantly, the brand presents the new line as skincare validated with the participation of dermatologists. This refers to the evaluation of testing protocols, results, safety, skin compatibility, and ingredient efficacy within the scope of cosmetic use. At the same time, Lancôme separately notes that Absolue Longevity MD is a cosmetic approach to influencing visible signs of aging through topical application and does not work in the same way as the oral Mitopure® supplement.
That is precisely why this launch requires careful and accurate communication. The topic of mitochondria, cellular energy, and biological age sounds compelling, but in skincare it is important to explain it without exaggeration. Such products do not “stop aging” and do not replace medical or aesthetic procedures. It is more accurate to view them as part of a broader direction related to supporting skin quality, barrier function, renewal, firmness, and a healthy appearance.
The launch also demonstrates the strengthening connection between premium skincare, biotechnology companies, and personalized skin diagnostics. Lancôme positions Absolue Longevity MD within its own Longevity Integrative Science™ approach, and the partnership with Timeline shows that ingredients from the healthy aging field are increasingly moving into premium cosmetics.
For the market, this may become one of the markers of a new stage in the anti-aging category. After the wave of interest in peptides, PDRN, exosomes, skin quality-improving products, and procedures aimed at skin restoration, major brands are beginning to shape yet another language of skincare—through mitochondrial function, cellular energy, and the skin’s long-term vitality.
Absolue Longevity MD is launching as a premium line with creams and serums within the Anticipate, Intercept, and Reset models. For the consumer, this will look like a new launch in the premium skincare segment, but for the professional industry, the direction itself is more important: skincare associated with the theme of skin longevity is moving out of the niche zone and becoming part of the global strategy of major cosmetics brands.
